ArticleClinical drug investigation2020

Comparison of the Effects of Secukinumab and Adalimumab Biosimilar on Radiographic Progression in Patients with Ankylosing Spondylitis: Design of a Randomized, Phase IIIb Study (SURPASS).

Xenofon Baraliakos et al.PubMed ↗Publisher ↗

No numbers read from the abstract.